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The hematoxylin-stainable protein (HSP) in keratohyalin granules of the newborn rat epidermis was found to have the same amino acid composition 
and the same inhibitory and immunological properties as cystatin z. However. only its pI talue (4.7) differed from that ofcystatin r (5.3). Alkaline 
phosphatase treatment of HSP changed Its pI value from 4.7 to 5.3. This pl change was inhibited by EDTA. an inhibitor of alkaline phosphatase. 
Furthermore, 3LP from [;lJ2P]ATP was incorporated into recombinant cystatin r by a protein kinase C (PKC) preparation in the presence of phos- 
phatidyl serine and Caz+ Ions as co-factors. The incorporation mcreased dose-dependently wth the added cystatin r and was inhibited significantly 
by H-7. a specific Inhibitor of PKC. SDS-PAGE autoradiography of the “‘P-labeled proteins showed that 3zP was Incorporated into the cystatin 
2. This Incorporation was not observed by the action of CAMP-dependent protein klnase. Therefore, it is highly possible that the HSP is a phospho- 
rylated cystatin LX and that the phosphorylation is catalyzed specltically by PKC‘. 
Phosphorylated cysteine proteinase inhibitor; Hematoxylin stainable protein: Cystatin Y 
I. INTRODUCTION 
In a previous study WC demonstrated the presence of 
cpstatin 01 in keratohyalin granules in the rat cpidormis 
in vivo and proposed that the hematoxylin-stainable 
protein (HSP) in these granules is a cystatin LY derivative 
[I]. Keratohyalirr granules arc known to contain a 
basic, histidine-rich protein, filaggrin [2], which is 
thought to he functionally related with the aggregation 
of keratin filaments [3J or the ~vater-holding capacity of 
the stratun~ corn~um [4]. In contrast, HSP, which is an 
acidic protein component of keratoh~alin granules 151, 
is similar to cystatin rri; both are cysteinc proteinase in- 
hibitors, and the two proteins have the same amino acid 
compositions, molecular lveights, and inhibitory and 
immunological properties. Hobvever, the pI LJ~ILI~ of 
cystatin (Y is 5.3 whereas that of HSP is 4.7, as shown 
by analytical isoelectric focusing [I]. This finding sug- 
gests that HSP is a phosphorylated form of cystatin (1, 
like the egg white cystatin reported by Laber et al. [6]. 
In this study, we investigated the dephosphorylation 
of HSP using an alkaline phosphatase and the 
phos~~horyJation of recombinant cystatin ix using a par- 
tially purified protein kinasc C (PKC). 
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big. I. Analytical isoelectric focujint: of HSP after treatment of 
alhahne phosphata\e. (a) Kccombinant qstatin N; (b) HSP treated 
with alkaline phopharase, ZnSO, and hlsS0~; (c) HSP trearcd \\ith 
alkaline phosphatase, FDTA; (d) alkaline phosphata$e. The arro\~ 
indicates newly produced cystatin (Y by treatment with alkaline 
phosphataw, which cho\\ed the same pl \aluc a, cyatatin u 
2.5. Cys/u/in wdepen&w/ incorporo1KIn o,f“lP 11110 /Jrorein h> PKC 
Recombinant cyatatin (Y or histonc III-S wa.$ incubated with 0.5 mA1 
CaCI:, IO mM M&I?, IO &I [yJLP]ATP, 20 &I of 0.5 mg/ml 
phosphatidyl 5erine, IO mhl 2.mercaptoethanol and partially pwticd 
PKC in 200~1 of 25 mhl Tris-HCI buffer (pH 7.5) for IO min at 37°C. 
The reaction was terminated by addins 20% trichlot-oacetic acid 
(TC‘A) and then 5q.0 TC.4 and 0.1% BSA \\cre added to precipitate 
the proteins. The precipitated protem was washed with 5O’o TCA and 
solubilired in 1 M NaOH [IO]. The inhibition analycls Ma5 aI50 per- 
formed in the presence of 2 mM of H-7. Cyctatin <Y-dependent incor- 
poration of ‘?P has aswyed by the Cerenkol effect [I I]. 
The material5 obtained in the alkaline phosphatase reaction sere 
subjected to analytical isoelectric focusing in the pH range of 4.0 to 
6.5 1121, and then the ,gel wa\ stained \\ith (‘oomassie brilliant blur. 
For the ob$ercation of the incorporation of “P into cy\tatin (v b) 
the action of PKC, cystattn (Y (100 pg) \\as incubated with a partialI! 
purifted PKC, 0.5 m&l CaCI:, IO mM LlgCI:, IO /I~I [Y-‘~P] ‘ATI’. 20 
~1 of 0.5 mg/ml phosphatidb I st-ine and IO mhl 2-rnercaptoethanol in 
200 ALI of 25 mL1 Tris-HCI buffer (pH 7.5). for 10 tnin at 37,‘C [IO]. 
The inhibitory effect of 20 mbl H-7 ~3s also examined. For the obscr- 
\*ation of the incorporation of ” 1’ into cystatin cz by the action of 
cAMP-dependent protein kinare, cystatin (Y (100 pg) \\as incubated 
v,ith IO mhl hlg(C‘HiCOO)l, 20 PM [y”P]ATP, I pll cA\lP and 
cAhlP-dependent protein kinase in 200 gI of 25 tnM Tri\-HCI buffcl 
(pH 7.5) for 10 min at 37°C [l3]. Thi\ inhibitor) effect of I ml\1 H-8 
\\a\ also euamincd. The reactions \\cre terminated bb the addition of 
TC‘A and then 5”0 TCA and 0. loo BSA were added to precipitate pro- 
tcins. The precipitates were washed Edith cold 90’? acetone to rernovc 
rCA and then folubililed in IQ SIX holution and sub.iected to SDS- 
PAGE in 15% acrylatnidc gzls [t-1]. 
3. RESULTS 
After treatment Lvith alkaline phosphatase, HSP 
changed from pI 4.7 to a protein band of pI 5.3 on 
isoelectric focusing (Fig. lb). This newly formed pro- 
tein band corresponded with that of recombinant 
cystatin (Y (Fig. la). This pl 5.3 protein band was not 
formed in the co-existence with an inhibitor of alkaline 
phosphatase (Fig. lc). 
Results on cystatin a-dependent and histone III-S- 
dependent incorporations of “P into protein fractions 
by partially purified PKC are shown in Table 1. “P was 
incorporated into both cystatin LY and histone III-S by 
activated PKC. The incorporation increased dose- 
dependently with added cystatin ~1 and was inhibited 
significantly by the addition of H-7, a specific inhibitor 
of PKC. To reconfirm that j2P was incorporated into 
the cystatin o( molecule, cystatin LY was treated with ac- 
tivated PKC and [“P]ATP under the same conditions 
as described above and then the “P-labeled proteins 
were examined by SDS-PAGE and autoradiography. 
As shown in Fig. 2, a clear band of “P-labeled protein 
was observed in the position of cystatin (Y (arrow). 
However, the incorporation of j2P into the cystatin 
band is inhibited completely in the presence of H-7 in- 
hibitor. In addition, this “P incorporation into cystatin 
CY was not observed by the action of CAMP-dependent 
protein kinase, although added histone was 
phosphorylated by the CAMP-dependent protein 
kinase. These findings suggested that HSP in 
keratohyalin granules of the epidermis could be a 
phosphorylated cystatin 01 and that the cystatin o( could 
be phosphorylated by the action of PKC during target- 
ting of cystatin 01 into the granules. 
Substrate 
Clstatin 01 ( 86 big) 
Cy\tatin ii’ ( X6 g$) 
Cystatin (Y (172 I@) 
Cy$tatin (Y (172 pg) 
Hiytonc ( 86 1~s) 
Hi,tonc ( X6 p*s) 
Table I 
Incorporation of “P into cystatin (Y by protein kinaje C 
Inhibitor “P incorporated into protein 
fraction (cpm) 
523.Y 
t H-7 348.0 
I L46.J 
+ H-7 711.4 
1363.1 
+ H-7 78Y.l 
6820.4 
t H-7 792.3 
“P incorporated into q’tatin (Y 
or hi\tone (cpm) 
672.3 
x3.3 
X39.3 
331.1 
6296.9 
333.3 
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tig. 2. SDS-PAGt autoradiography of “P incorporation into 
cptatin <x. The $el ~a$ stained with Coomasie brilliant blue wlution 
(A) and also cxamined by autoradiography (B). For the latter , the 
dried gel aas exposed to Fuji X-ray film for 5 daqr. The arro\\s 
indlcatc the band of cystatin rr. (a) cystatin (\ treated with PKC; (b) 
cystarin u treated with PKC in the presence or F1-7: (c) cptatin (Y 
treated with cA.1lP-dependent protein kina,e; (d) cptatin (1 treated 
v.irh cAMP-dependent protein kinale in the presence of b-1-8; (m) 
molecular \+eight marker5 (top to bottom): phophorylaw B (94 kDa), 
bovine wum albumin (67 kDa), ovalbumm (43 kDo), carbonic 
anhldrase (30 kl)a), soybean tryprin inhibitor (20.1 klIa), 
lacralbumin (14.4 kna). 
4. DISCUSSION 
The inhibitory activity of HSP was quite similar to 
cystatin CY as previously reported [ 11. Since both these 
proteins immunologically cross-reacted [I], they should 
have many common epitopes in their molecular struc- 
ture. The only known difference between these two pro- 
teins is that the isoelectric point of HSP is 4.7, whereas 
that of cystatin cy is 5.3. Takeda et al. reported cystatin 
N derivatives uith higher isoelectric points than that of 
cystatin cy, due to the elimination of acidic amino acids 
from the N-terminal region 1151. In preliminary studies, 
we found that the N-terminus of HSP is masked, but 
that several amino acids in its C-terminal region are 
identical with those in cystatin 01. Moreover, no protein 
spot with a higher- isoelectric point was observed when 
the epidermal extract was examined with antibodies to 
cystatin cy or by protein staining for cystatin 01. These 
findings suggested that HSP might have a different 
isoelectric point from that of cystatin CY because it is 
phosphorylated, like egg white cystatin [6]. In the pre- 
sent investigation we found that on treatment of HSP 
with alkaline phosphatase, its p1 value shifted to that of 
cystatin 01, although the amount of protein migration 
was low. The negative charges of the phosphate moiety 
could be responsible for lowering the isoelectric point 
from 5.3 (cystatin cy) to 4.7 (HSP). It is unknown why 
so little reaction product was obtained on treatment 
with alkaline phosphatase (Fig. lb). 
The preparation of PKC used in this work was not 
pure enough, and still contained some phophorylatable 
180 
proteins by CPK. .41so, phosphorylatable site(s) in 
cystatin 01 molecule must be small in number(s) com- 
pared to histone. Although only a small amount of “P 
was incorporated into cystatin (v, the incorporation in- 
creased with higher concentrations of cystatin 01 added. 
X-ray crystallographic studies have shown that the 
binding site with the cathepsins is located in N-terminal 
region [ 161. Moreo\,er, pre\ ious observations showed 
that the inhibitory profiles of cystatin cx and HSP are 
similar. Thus the site is probably phosphorylated in the 
C-terminal region which is not important for the in- 
hibitory activity. The amino acid in the HSP molecule 
that is phosphorylated is probably a serine or threonine 
residue because HSP did not [react with anti- 
phosphotyrosine monoclonal antibody (data not 
shown). In addition, this “P incorporation could be a 
specific action of PKC, because “P was not incor- 
porated into cystatin o( by the action of cAMP- 
dependent protein kinase. 
In general, serine or threonine located between basic 
amino acids are easily phosphorylated by PKC. From 
these aspects, it is possible to speculate that the possible 
phosphorylating site of cystatin OY is the threonine in the 
-N-K-T-K-N- sequence located near the C-terminus. It 
will be confirmed in the near future. 
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